Kauseruzzaman A Khan, MD | |
3524 E Milwaukee St, Janesville, WI 53546-1626 | |
(608) 756-7100 | |
(608) 741-4700 |
Full Name | Kauseruzzaman A Khan |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 32 Years |
Location | 3524 E Milwaukee St, Janesville, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093724304 | NPI | - | NPPES |
KHANKAU | Other | WI | MERCYCARE INSURANCE |
34402400 | Medicaid | WI | |
P00403325CD3624 | Other | WI | RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 45246 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Health System Corp | Janesville, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aurora Medical Group, Inc. | 6709794258 | 3207 |
Mercy Health System Corporation | 7416860440 | 459 |
News Archive
A study at Hospital for Special Surgery finds that a support group addressing the psychological and educational needs of people recently diagnosed with rheumatoid arthritis (RA) has a strong positive impact on their lives.
Northwestern University researchers have developed a novel, three-dimensional model that allows scientists to observe how interacting with the microenvironment of metastatic melanoma cells induces normal skin cells to become similar to aggressive cancer cells that migrate and spread throughout the body.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
"The U.S. government will soon be asking university officials to comment on how best to implement recently released dual use research rules at the university level," according to Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID), who spoke Monday at a workshop sponsored by the National Academies in Washington, ScienceInsider reports.
› Verified 3 days ago
Entity Name | Aurora Medical Group, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
A study at Hospital for Special Surgery finds that a support group addressing the psychological and educational needs of people recently diagnosed with rheumatoid arthritis (RA) has a strong positive impact on their lives.
Northwestern University researchers have developed a novel, three-dimensional model that allows scientists to observe how interacting with the microenvironment of metastatic melanoma cells induces normal skin cells to become similar to aggressive cancer cells that migrate and spread throughout the body.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
"The U.S. government will soon be asking university officials to comment on how best to implement recently released dual use research rules at the university level," according to Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID), who spoke Monday at a workshop sponsored by the National Academies in Washington, ScienceInsider reports.
› Verified 3 days ago
Entity Name | Mercy Health System Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598718603 PECOS PAC ID: 7416860440 Enrollment ID: O20031113000164 |
News Archive
A study at Hospital for Special Surgery finds that a support group addressing the psychological and educational needs of people recently diagnosed with rheumatoid arthritis (RA) has a strong positive impact on their lives.
Northwestern University researchers have developed a novel, three-dimensional model that allows scientists to observe how interacting with the microenvironment of metastatic melanoma cells induces normal skin cells to become similar to aggressive cancer cells that migrate and spread throughout the body.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
"The U.S. government will soon be asking university officials to comment on how best to implement recently released dual use research rules at the university level," according to Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID), who spoke Monday at a workshop sponsored by the National Academies in Washington, ScienceInsider reports.
› Verified 3 days ago
Entity Name | Beaver Dam Community Hospitals Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972188555 PECOS PAC ID: 2567370539 Enrollment ID: O20040210000666 |
News Archive
A study at Hospital for Special Surgery finds that a support group addressing the psychological and educational needs of people recently diagnosed with rheumatoid arthritis (RA) has a strong positive impact on their lives.
Northwestern University researchers have developed a novel, three-dimensional model that allows scientists to observe how interacting with the microenvironment of metastatic melanoma cells induces normal skin cells to become similar to aggressive cancer cells that migrate and spread throughout the body.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
"The U.S. government will soon be asking university officials to comment on how best to implement recently released dual use research rules at the university level," according to Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID), who spoke Monday at a workshop sponsored by the National Academies in Washington, ScienceInsider reports.
› Verified 3 days ago
Entity Name | Baycare Aurora Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255387726 PECOS PAC ID: 0244130557 Enrollment ID: O20051012000579 |
News Archive
A study at Hospital for Special Surgery finds that a support group addressing the psychological and educational needs of people recently diagnosed with rheumatoid arthritis (RA) has a strong positive impact on their lives.
Northwestern University researchers have developed a novel, three-dimensional model that allows scientists to observe how interacting with the microenvironment of metastatic melanoma cells induces normal skin cells to become similar to aggressive cancer cells that migrate and spread throughout the body.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
"The U.S. government will soon be asking university officials to comment on how best to implement recently released dual use research rules at the university level," according to Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID), who spoke Monday at a workshop sponsored by the National Academies in Washington, ScienceInsider reports.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Kauseruzzaman A Khan, MD 3524 E Milwaukee St, Janesville, WI 53546-1626 Ph: (608) 756-7100 | Kauseruzzaman A Khan, MD 3524 E Milwaukee St, Janesville, WI 53546-1626 Ph: (608) 756-7100 |
News Archive
A study at Hospital for Special Surgery finds that a support group addressing the psychological and educational needs of people recently diagnosed with rheumatoid arthritis (RA) has a strong positive impact on their lives.
Northwestern University researchers have developed a novel, three-dimensional model that allows scientists to observe how interacting with the microenvironment of metastatic melanoma cells induces normal skin cells to become similar to aggressive cancer cells that migrate and spread throughout the body.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
"The U.S. government will soon be asking university officials to comment on how best to implement recently released dual use research rules at the university level," according to Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID), who spoke Monday at a workshop sponsored by the National Academies in Washington, ScienceInsider reports.
› Verified 3 days ago
Imdad Ahmed, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6868 Fax: 608-756-6289 | |
Jacob A Thomas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6741 Fax: 608-756-6376 | |
David R. Isaacson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6261 Fax: 068-756-6236 | |
Dr. Fahim Haider Jafary, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6868 | |
William N Brandt, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000 Fax: 608-371-8277 | |
Kathryn A Lilley, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000 Fax: 608-371-8939 |